RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Attention to and distraction from risk information in prescription drug advertising
An eye-tracking study
Sullivan, H. W., Boudewyns, V., O'Donoghue, A., Marshall, S., & Williams, P. A. (2017). Attention to and distraction from risk information in prescription drug advertising: An eye-tracking study. Journal of Public Policy & Marketing, 36(2), 236-245. https://doi.org/10.1509/jppm.16.013
Direct-to-consumer (DTC) television ads must disclose a drug's most important risks. Currently, the risks must be presented in audio at a minimum. Studies have shown that presenting information with both audio and superimposed risk text (dual modality) improves recall beyond what is achieved using audio alone. However, distracting elements in DTC adsmay draw attention away fromthe superimposed risk text. This study combines eye-tracking data with questionnaire data to examine whether distracting elements decrease attention to the risk text in DTC ads, in turn affecting risk retention and risk perceptions. The authors randomly assign 300 U.S. opt-in panel members to view either a low-distraction or a high-distraction DTC television ad. The authors find that distracting elements during risk presentation drew attention away from the risk text and, in turn, reduced retention of drug risk information. Risk perceptions were not affected. These results suggest that even if dual modality is used to increase consumers' comprehension of drug risk information, distracting visuals should still be avoided to help consumers focus on key information in the ad.